Hims & Hers Health (HIMS) CFO reports option exercise and stock sale

Rhea-AI Filing Summary

Hims & Hers Health Chief Financial Officer Oluyemi Okupe reported option exercises and a stock sale involving Class A common stock. On January 5, 2026, Okupe exercised stock options for 2,178 shares at $5.01 and 3,808 shares at $11.53 per share, receiving the same number of Class A shares. On the same day, Okupe sold 9,070 shares of Class A common stock at an average price of $33.7875.

The filing states that these option exercises and sales were carried out under a Rule 10b5-1 trading plan adopted on May 21, 2025. After the reported transactions, Okupe directly held 91,617 Class A shares and indirectly held 7,853 additional shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/05/2026		M(1)		2,178	A	$5.01	96,879(2)	D
Class A Common Stock	01/05/2026		M(1)		3,808	A	$11.53	100,687	D
Class A Common Stock	01/05/2026		S(1)		9,070	D	$33.7875(3)	91,617	D
Class A Common Stock								7,853	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	01/05/2026		M(1)			2,178	(4)	02/23/2032	Class A Common Stock	2,178	$0	156,630	D
Stock Option (right to buy)	$11.53	01/05/2026		M(1)			3,808	(5)	03/01/2033	Class A Common Stock	3,808	$0	44,746	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

2. Includes 368 shares acquired on November 20, 2025, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.

3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.61-$33.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

4. The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.

5. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did HIMS CFO Oluyemi Okupe report on January 5, 2026?

On January 5, 2026, Hims & Hers Health CFO Oluyemi Okupe exercised stock options for 2,178 shares at $5.01 and 3,808 shares at $11.53, and sold 9,070 shares of Class A common stock at an average price of $33.7875.

How many HIMS shares does the CFO hold after these transactions?

Following the reported transactions, CFO Oluyemi Okupe directly owned 91,617 shares of Hims & Hers Health Class A common stock and indirectly held 7,853 shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

Were the HIMS CFO’s trades made under a Rule 10b5-1 trading plan?

Yes. The filing explains that the stock option exercises and sales were effected under a Rule 10b5-1 trading plan adopted on May 21, 2025 by the reporting person.

What prices were involved in the HIMS CFO’s option exercises and share sale?

The CFO exercised options at $5.01 and $11.53 per share. The 9,070 shares sold were executed at an average weighted price of $33.7875, with individual sale prices ranging from $33.61 to $33.98.

What type of securities did the HIMS CFO exercise on January 5, 2026?

The transactions involved stock options (rights to buy) for Hims & Hers Health Class A common stock, covering 2,178 shares with a $5.01 exercise price and 3,808 shares with an $11.53 exercise price.

How do the HIMS CFO’s stock options vest according to the filing?

One option grant vests over 4 years with 1/48 of the shares vesting monthly beginning March 24, 2022. A second grant also vests over 4 years, with 1/48 vesting monthly beginning April 1, 2023.

What additional HIMS shares are noted from the employee stock purchase plan?

The filing notes that the CFO’s holdings include 368 shares acquired on November 20, 2025 under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.